Initiator Pharma A/S: Financial statements 2019
CVR: 37663808
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -8,366,000 and a net result of DKK -8,288,000 compared with DKK -10,298,000 the year before. Equity in the 2019 report amounted to DKK 9,908,000. The solvency ratio was 86.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -8,366,000
- Profit/Loss
- DKK -8,288,000
- Equity
- DKK 9,908,000
- Total Assets
- DKK 11,438,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -8.4M | -8.3M | 9.9M | 1 |
| 2018 | - | -11.4M | -10.3M | 16.6M | 1 |
| 2017 | - | -8.2M | -8.6M | 6M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Initiator Pharma A/S has published its annual report for 2018. Gross profit came to DKK -11,437,000, and the net result was DKK -10,298,000.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
